Central Alerting System
View Alert
Versions:


Originator: National Patient Safety Alert - DHSC

Issue date: Originally issued on 23-Jan-2023 15:17:25. This version was issued on 23-Jan-2023 15:17:25

This alert has been issued to:
  • Care Trusts
  • Mental Health Trusts
  • Specialists Trusts
  • Learning Disabilities Trusts
  • Mental Health & Social Care Trusts
  • Ambulance Trusts
  • Mental Health & Learning Disabilities Trusts
  • Acute Trusts
  • Community Trusts

  • Other contacts
  • Independent Healthcare Providers (registered with CAS)
  • Clinical Commissioning Groups
  • Special Health Authorities
  • Territorial CMOs in Northern Ireland, Scotland & Wales
  • DHSC Supply Disruption - Medicines

Action category: Action

Title: Supply of Licensed and Unlicensed Epidural Infusion Bags

Broadcast content: There are supply issues impacting Fresenius Kabi (FK) unlicensed epidural bags containing bupivacaine only and levobupivacaine with fentanyl. These are also impacting Sintetica’s licensed epidural bags containing bupivacaine only and bupivacaine with fentanyl.

This National Patient Safety Alert contains actions for acute care hospitals, and any other organisations providing procedures that require epidural infusions.


Additional information: This alert is not relevant to Primary Care.

Alert reference: NatPSA/2023/002/CMU

Action underway deadline: 25-Jan-2023

Action complete deadline: 27-Jan-2023

Attachments:

Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency